Loading...

Loading...

Should UNOPS Be Accountable Before INAI?
By Antonio Gozain - Thu, 11/04/2021 - 11:43
UNOPS must account for the public resources it has received for the purchase of medicines and medical supplies abroad, argues former commissioner.
https://mexicobusiness.news/tag/medicine-purchase-schemes
More Health
Midterm Elections’ Impact on Healthcare
By Miriam Bello - Mon, 06/14/2021 - 15:05
After many controversial reform proposals during AMLO’s administration, the sector sees a calmer future.
UNOPS Brings Savings, Unfulfilled Contracts, Medicine Shortages
By Miriam Bello - Tue, 06/01/2021 - 15:05
Changes to medicines purchasing schemes brought savings but also several problems.
Innovation to Relieve a Suffocated Sector
By Miriam Bello - Fri, 04/16/2021 - 09:23
Chiesi’s priorities focus on propelling innovation in Mexico by breaking bureaucratic barriers that slow progress.
Medicine Distribution Compromised Once More
By Miriam Bello - Thu, 03/18/2021 - 12:08
Public medicine tenders faced a challenging 2020. Have lessons not been learnt? Here is the Week in Health!
 How to Thrive in the New Centralized Purchasing Schemes
By Mónica López - Mon, 02/15/2021 - 11:59
Industry players unite to solve the current health situation in Mexico. Mexico Health Summit covers the government’s centralized purchasing scheme.
Dialogue is Essential to Ensure Quality Treatments: Chiesi
By Jan Hogewoning - Wed, 01/27/2021 - 21:07
Director General of Chiesi Mexico, Marco Ruggiero explains how medicine purchasing schemes have impacted the industry and Chiesi's place as a provider
Excellence Through Technology
By Miriam Bello - Wed, 01/27/2021 - 17:11
Medistik offers specialized services for healthcare distribution depending on the provider. Find out more about their solutions for a complex industry
How to Thrive in the New Centralized Purchasing Schemes
By Miriam Bello - Wed, 01/27/2021 - 13:41
Industry players unite to solve the current health situation in Mexico. Mexico Health Summit covers the government’s centralized purchasing scheme.
Quality, Accessible Medicine For Out-Of-Pocket Patients
By Miriam Bello - Mon, 12/14/2020 - 14:38
The national generics industry has enjoyed double-digit growth during the COVID-19 crisis. DILAMEG Director General Arturo Manriquez explains why.